Catalyst Pharmaceuticals Says Co’s, KYE Pharmaceuticals’ Lawsuit In Canadian Federal Court ‘Quashes The Notice of Compliance (NOC) For Ruzurgi’
Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for
